Ezekizumab is mainly used in the treatment of psoriasis, the drug works faster and studies have shown significant improvement after 7 days of using this product compared to placebo. Ezekizumab is used to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It takes effect relatively quickly, with the majority of patients generally showing improvement after 7 days of dosing. Clinical trials have shown that after 12 weeks of use, the condition of most patients will have significant improvement, and adherence to the drug can achieve a more satisfactory therapeutic effect. Common adverse reactions include upper respiratory tract infection, herpes simplex, oropharyngeal pain, nausea, etc. It is contraindicated for those who are allergic to the product as well as important active infections. This product needs to be used consistently for a long time, please follow the doctor’s instructions with the help of a physician to give medication regularly, do not arbitrarily stop taking medication.